financetom
Business
financetom
/
Business
/
India's Hindalco beats Q2 profit view on higher aluminium prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's Hindalco beats Q2 profit view on higher aluminium prices
Nov 11, 2024 6:18 AM

Nov 11 (Reuters) - India's Hindalco Industries

, one of the country's largest aluminium and copper

producers, posted a higher-than-expected second-quarter profit

on Monday, helped by higher aluminium prices.

The company, owned by the Aditya Birla Group, said its

consolidated net profit jumped 78% to 39.09 billion rupees

($463.3 million) for the three months ended Sept. 30, beating

estimates.

Analysts, on average, had expected a profit of 34.46 billion

rupees, according to data compiled by LSEG.

($1 = 84.3700 Indian rupees)

(Reporting by Anuran Sadhu in Bengaluru; Editing by Sumana

Nandy and Abinaya Vijayaraghavan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
10x Genomics Reaches $68 Million Patent Settlement With Bruker
10x Genomics Reaches $68 Million Patent Settlement With Bruker
May 26, 2025
05:56 PM EDT, 05/14/2025 (MT Newswires) -- 10x Genomics ( TXG ) said Wednesday it reached a settlement agreement with Bruker ( BRKR ) to resolve all worldwide patent litigation and disputes between the two companies. As part of the deal, Bruker ( BRKR ) will pay $68 million to 10x Genomics ( TXG ) in equal quarterly installments from...
AbCellera Biologics Gets Health Canada Approval for Phase 1 Trial of Menopause Treatment
AbCellera Biologics Gets Health Canada Approval for Phase 1 Trial of Menopause Treatment
May 26, 2025
05:53 PM EDT, 05/14/2025 (MT Newswires) -- AbCellera Biologics ( ABCL ) said Health Canada authorized its clinical trial application for a phase 1 study of an investigational antibody medicine designed for the non-hormonal treatment of moderate-to-severe vasomotor symptoms, known as hot flashes, associated with menopause. The trial for ABCL635 is expected to begin in Q3 and will evaluate the...
Applovin Insider Sold Shares Worth $4,237,397, According to a Recent SEC Filing
Applovin Insider Sold Shares Worth $4,237,397, According to a Recent SEC Filing
May 26, 2025
05:57 PM EDT, 05/14/2025 (MT Newswires) -- Craig Scott Billings, Director, on May 12, 2025, sold 12,000 shares in Applovin ( APP ) for $4,237,397. Following the Form 4 filing with the SEC, Billings has control over a total of 2,987 Class A common shares of the company, with 2,987 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218025003833/xslF345X05/primarydocument.xml ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved